Showing 1 to 5 of 5 results for mirabegron
Evidence-based recommendations on mirabegron (Betmiga) for treating overactive bladder in adults.
In development [GID-TA11348] Expected publication date: TBC
Awaiting development [GID-TA11105] Expected publication date: TBC
This guideline covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions.
This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.